Zobrazeno 1 - 10
of 1 562
pro vyhledávání: '"Dino, Amadori"'
Autor:
Chiara Liverani, Alessandro De Vita, Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Alberto Bongiovanni, Anna De Lucia, Federico La Manna, Francesco Fabbri, Michela Tebaldi, Dino Amadori, Ennio Tasciotti, Giovanni Martinelli, Laura Mercatali, Toni Ibrahim
Publikováno v:
Molecular Oncology, Vol 16, Iss 4, Pp 921-939 (2022)
To improve the success rate of current preclinical drug trials, there is a growing need for more complex and relevant models that can help predict clinical resistance to anticancer agents. Here, we present a three‐dimensional (3D) technology, based
Externí odkaz:
https://doaj.org/article/7f50673868da47039920d747cb127b18
Evaluating the appropriateness of chemotherapy in a low‐resource cancer centre in sub‐Saharan Africa
Autor:
Patrizia Serra, Deogratias M. Katabalo, Nestory Masalu, Dino Amadori, Salustia Bugingo, Flavia Foca, Sara Bravaccini, Caterina Donati, Lauro Bucchi, Carla Masini
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 133-140 (2020)
Abstract Background To evaluate the appropriateness of chemotherapy use at the Oncology Department of the Bugando Medical Centre of Mwanza, Tanzania. Methods The study was an observational prevalence‐based study designed to evaluate a single‐chem
Externí odkaz:
https://doaj.org/article/b7a637a2c59f4ef6aa4d418e50d858e8
Autor:
Sara Bravaccini, Patrizia Serra, Dino Amadori, Mattia Altini, Nestory Masalu, Deogratias Katabalo, Lauro Bucchi, Carla Masini
Publikováno v:
Annals of Global Health, Vol 87, Iss 1 (2021)
One of the major problems facing healthcare systems in countries with poor socioeconomic conditions is the need to strengthen the system through the training of physicians, nurses and other healthcare operators. Partnering with more affluent countrie
Externí odkaz:
https://doaj.org/article/d49eb34b224e4c1b80d88ac00bf3a384
Autor:
Alberto Visioli, Fabrizio Giani, Nadia Trivieri, Riccardo Pracella, Elide Miccinilli, Maria Grazia Cariglia, Orazio Palumbo, Andrea Arleo, Fabio Dezi, Massimiliano Copetti, Laura Cajola, Silvia Restelli, Valerio Papa, Antonio Sciuto, Tiziana Pia Latiano, Massimo Carella, Dino Amadori, Giulia Gallerani, Riccardo Ricci, Sergio Alfieri, Graziano Pesole, Angelo L. Vescovi, Elena Binda
Publikováno v:
EBioMedicine, Vol 44, Iss , Pp 346-360 (2019)
Background: Despite their lethality and ensuing clinical and therapeutic relevance, circulating tumor cells (CTCs) from colorectal carcinoma (CRC) remain elusive, poorly characterized biological entities. Methods and findings: We perfected a cell sys
Externí odkaz:
https://doaj.org/article/1f869219eef84cd3b7742e7ad0525533
Autor:
Vincenza Conteduca, Giorgia Gurioli, Lorena Rossi, Emanuela Scarpi, Cristian Lolli, Giuseppe Schepisi, Alberto Farolfi, Delia De Lisi, Valentina Gallà, Salvatore Luca Burgio, Cecilia Menna, Andrea Amadori, Lorena Losi, Dino Amadori, Maria Paola Costi, Ugo De Giorgi
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background The purpose of this study was to evaluate the clinical impact of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in terms of the response rate, progression-free/overall survival (PFS/OS) and safety profile in p
Externí odkaz:
https://doaj.org/article/c7bf734d511e401a9cedd3755dfa4a9a
Autor:
Alberto Bongiovanni, Federica Recine, Flavia Foca, Valentina Fausti, Nada Riva, Greta Fabbri, Stefano Severi, Chiara Liverani, Alessandro De Vita, Chiara Spadazzi, Giacomo Miserocchi, Laura Mercatali, Dino Amadori, Toni Ibrahim
Publikováno v:
Endocrine Connections, Vol 7, Iss 12, Pp 1535-1541 (2018)
The incidence of neuroendocrine neoplasia (NEN) is higher in individuals ≥70 years of age (elderly) who are underrepresented in clinical trials because of comorbidities and low performance status. We retrospectively analyzed the outcome of elderly
Externí odkaz:
https://doaj.org/article/ff98511a34394123b075e9563e09b048
Autor:
Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori, Anna Fedeli
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzuma
Externí odkaz:
https://doaj.org/article/80cb6bee9a8f421483a798d7d407304c
Autor:
Elisabetta Petracci, Emanuela Scarpi, Alessandro Passardi, Annibale Biggeri, Carlo Milandri, Stefano Vecchia, Fabio Gelsomino, Davide Tassinari, Stefano Tamberi, Ilaria Bernardini, Caterina Accettura, Giovanni Luca Frassineti, Dino Amadori, Oriana Nanni
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Cancer trials involving multiple treatment lines substantially increase our understanding of therapeutic strategies. However, even when the primary end-point of these studies is progression-free survival (PFS), their statistical analysis
Externí odkaz:
https://doaj.org/article/f2076c860f5b400f8b894c34d14186f5
Autor:
Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast can
Externí odkaz:
https://doaj.org/article/9c335358d56743fda946544b114d2f88
Autor:
Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, Maurizio Puccetti, Emanuela Scarpi, Daniele Andreis, Maria Maddalena Tumedei, Samanta Sarti, Lorenzo Cecconetto, Elisabetta Pietri, Valeria De Simone, Roberta Maltoni, Massimiliano Bonafè, Dino Amadori, Andrea Rocca
Publikováno v:
Translational Oncology, Vol 11, Iss 4, Pp 950-956 (2018)
Genomic studies have shown that the androgen receptor (AR) pathway plays an important role in some breast cancer subtypes. However few data are present on the concordance between AR expression in primary tumors and metastases. We investigated AR expr
Externí odkaz:
https://doaj.org/article/7530afb9d90a49539d950ceec717d50d